Display options
Share it on

Mol Med. 2020 Feb 03;26(1):17. doi: 10.1186/s10020-020-0142-x.

Expression of concern to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome.

Molecular medicine (Cambridge, Mass.)

Karin Palmblad, Hanna Schierbeck, Erik Sundberg, Anna-Carin Horne, Helena Erlandsson Harris, Jan-Inge Henter, Daniel J Antoine, Ulf Andersson

Affiliations

  1. Unit of Pediatric Rheumatology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden. [email protected].
  2. Unit of Pediatric Rheumatology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden. [email protected].
  3. Unit of Pediatric Rheumatology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  4. Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  5. Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  6. Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.

PMID: 32013863 PMCID: PMC6998297 DOI: 10.1186/s10020-020-0142-x

[No abstract available.]

References

  1. Palmblad K, et al. High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome. Mol Med. 2014;20:538–47 https://molmed.biomedcentral.com/articles/10.2119/molmed.2014.00183 . - PubMed

Publication Types